SEC Form 4 · accession 0000932440-15-000159
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jay Moorin
10% Owner
Alain Schreiber
10% Owner
ProQuest Investments IV, L.P.
10% Owner
ProQuest Associates IV LLC
10% Owner
Period of report
May 12, 2015
Accepted (ET)
May 13, 2015 · 9:38 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | May 12, 2015 | S | 22,607 | $22.26 | D | 2,138,858 | D | |
| Common StockF1 | May 12, 2015 | S | 155,000 | $21.50 | D | 1,983,858 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., each of whom may be deemed to have shared voting, investment and dispositive power with respect to these securities. Each individual managing member disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
- F2Constitutes the weighted average sale price for multiple transactions reported on this line having prices per share ranging from $22.20 to $22.63. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.